Skip to content
BidBenchmark

Contract award

NOVARTIS PHARMACEUTICALS CORPORATION

PLUVICTO
PIID
36C25226N0246
Award key
CONT_AWD_36C25226N0246_3600_36F79720D0180_3600
Recipient UEI
NG61ZA8TADW3
Parent award
CONT_IDV_36F79720D0180_3600
Source as of
Current award value
$823,0623
Obligated to date
$823,0622
Potential with options
$823,0623
Awarding agency
Department of Veterans AffairsDepartment of Veterans Affairs
Place of performance
East Hanover, New Jersey
Set-aside
None
Pricing
Firm Fixed Price
Competition
Full and Open Competition1 offers received
Period of performance
Feb 1, 2026Sep 30, 2026Through Sep 30, 2026 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Jan 29, 2026Initial award$685,885.20$823,062.24
P00001Aug 7, 2026B$137,177.04$823,062.24

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2442d0785c5cd
contractor_idUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2442d0785c5cd
current_award_valueUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2442d0785c5cd
naics_codeUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2442d0785c5cd
potential_award_valueUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2442d0785c5cd
psc_codeUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2442d0785c5cd
total_obligatedUSAspending.govAug 10, 2026usaspending_contract_csv@2026.08.2442d0785c5cd

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 2 transaction records parsed from USAspending.gov, retrieved Aug 10, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
36C25226N0246 — NOVARTIS PHARMACEUTICALS CORPORATION · BidBenchmark